99 related articles for article (PubMed ID: 25280656)
21. Assessment of percutaneous fine needle aspiration cytology as a technique to provide diagnostic and prognostic information in neuroblastoma.
Thiesse P; Hany MA; Combaret V; Ranchère-Vince D; Bouffet E; Bergeron C
Eur J Cancer; 2000 Aug; 36(12):1544-51. PubMed ID: 10930802
[TBL] [Abstract][Full Text] [Related]
22. Comparing safety and adequacy between surgical biopsy versus core needle biopsy in diagnosing neuroblastoma.
Mohamed H; Pastor MC; Langlois S; Cowan KN
J Pediatr Surg; 2022 May; 57(5):866-870. PubMed ID: 35086681
[TBL] [Abstract][Full Text] [Related]
23. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
24. Neuroblastoma--a surgical perspective.
Losty P; Quinn F; Breatnach F; O'Meara A; Fitzgerald RJ
Eur J Surg Oncol; 1993 Feb; 19(1):33-6. PubMed ID: 8436238
[TBL] [Abstract][Full Text] [Related]
25. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
26. Successful liver transplantation in an infant with stage 4S(M) neuroblastoma.
Steele M; Jones NL; Ng V; Kamath B; Avitzur Y; Chami R; Cutz E; Fecteau A; Baruchel S
Pediatr Blood Cancer; 2013 Mar; 60(3):515-7. PubMed ID: 23152322
[TBL] [Abstract][Full Text] [Related]
27. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
[TBL] [Abstract][Full Text] [Related]
28. Percutaneous biopsy for the diagnosis, risk stratification, and molecular profiling of neuroblastoma: A single-center retrospective study.
Schoeman S; Bagatell R; Cahill AM; Maris J; Mattei P; Mosse Y; Pogoriler J; Srinivasan A; Acord M
Pediatr Blood Cancer; 2024 Apr; 71(4):e30887. PubMed ID: 38291721
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for scoliosis in children with neuroblastoma.
Paulino AC; Fowler BZ
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):865-9. PubMed ID: 15708267
[TBL] [Abstract][Full Text] [Related]
30. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
Spitz R; Hero B; Simon T; Berthold F
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
[TBL] [Abstract][Full Text] [Related]
31. Interactive MR imaging-guided biopsy and aspiration with a modified clinical C-arm system.
Lewin JS; Petersilge CA; Hatem SF; Duerk JL; Lenz G; Clampitt ME; Williams ML; Kaczynski KR; Lanzieri CF; Wise AL; Haaga JR
AJR Am J Roentgenol; 1998 Jun; 170(6):1593-601. PubMed ID: 9609180
[TBL] [Abstract][Full Text] [Related]
32. MYCN protein expression as a predictor of neuroblastoma prognosis.
Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
[TBL] [Abstract][Full Text] [Related]
33. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
34. Ultrasound-guided core needle biopsy for the diagnosis of rhabdomyosarcoma in childhood.
Chowdhury T; Barnacle A; Haque S; Sebire N; Gibson S; Anderson J; Roebuck D
Pediatr Blood Cancer; 2009 Sep; 53(3):356-60. PubMed ID: 19418540
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of open and needle biopsies in tumors of the sacrum.
Ozerdemoglu RA; Thompson RC; Transfeldt EE; Cheng EY
Spine (Phila Pa 1976); 2003 May; 28(9):909-15. PubMed ID: 12942007
[TBL] [Abstract][Full Text] [Related]
36. Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.
Matthay KK; Brisse H; Couanet D; Couturier J; Bénard J; Mosseri V; Edeline V; Lumbroso J; Valteau-Couanet D; Michon J
Cancer; 2003 Jul; 98(1):155-65. PubMed ID: 12833468
[TBL] [Abstract][Full Text] [Related]
37. Monitoring diagnostic accuracy and complications. A report from the Children's Oncology Group Hodgkin lymphoma study.
Ehrlich PF; Friedman DL; Schwartz CL;
J Pediatr Surg; 2007 May; 42(5):788-91. PubMed ID: 17502184
[TBL] [Abstract][Full Text] [Related]
38. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies.
van Noesel MM; Hählen K; Hakvoort-Cammel FG; Egeler RM
Cancer; 1997 Sep; 80(5):834-43. PubMed ID: 9307181
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic ultrasound-guided cutting needle biopsies in neuroblastoma: A safe and efficient procedure.
Georgantzi K; Sköldenberg E; Janson ET; Jakobson Å; Christofferson R
J Pediatr Surg; 2019 Jun; 54(6):1253-1256. PubMed ID: 30700386
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcomes in patients with stage IV neuroblastoma.
Escobar MA; Grosfeld JL; Powell RL; West KW; Scherer LR; Fallon RJ; Rescorla FJ
J Pediatr Surg; 2006 Feb; 41(2):377-81. PubMed ID: 16481255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
